Edition:
United States

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

8,320JPY
8:37pm EDT
Change (% chg)

¥30 (+0.36%)
Prev Close
¥8,290
Open
¥8,330
Day's High
¥8,340
Day's Low
¥8,280
Volume
23,200
Avg. Vol
123,145
52-wk High
¥12,480
52-wk Low
¥8,280

Latest Key Developments (Source: Significant Developments)

Biofermin Pharmaceutical announces change of chairman
Wednesday, 28 Jun 2017 12:43am EDT 

June 28(Reuters) - Biofermin Pharmaceutical Co Ltd <4517.T>:Says it appoints Ken Uehara as new chairman.Effective June 28.  Full Article

Vietnam's Dhg Pharmaceutical says Q2 net profit down 1.3 pct y/y
Wednesday, 20 Jul 2016 05:34am EDT 

Dhg Pharmaceutical Joint-Stock Co : Vietnam's Dhg Pharmaceutical Co says Q2 net profit down 1.3 percent y/y at 147 billion dong ($6.6 million) Further company coverage: [DHG.HM] (Reporting By Mai Nguyen) ((mai.nguyen@thomsonreuters.com;)).  Full Article

Taisho Pharmaceutical Holdings unit signs agreement regarding allergic disease therapeutic agent
Thursday, 14 Jul 2016 10:59pm EDT 

Taisho Pharmaceutical Holdings Co Ltd <4581.T>:Says its unit Taisho Pharmaceutical signed agreement (contract for the license and commercialization) for an allergic disease therapeutic agent regarding OTC drugs in Japan with Bayer Yakuhin, Ltd., on July 11.  Full Article

Taisho Pharmaceutical Holdings unit buys shares of Duoc Hau Giang Pharmaceutical JSC
Tuesday, 5 Jul 2016 02:41am EDT 

Taisho Pharmaceutical Holdings Co Ltd <4581.T>: Says its unit acquired 24.5 percent stake in Vietnam-based co Duoc Hau Giang Pharmaceutical JSC on July 4 .Says Duoc Hau Giang Pharmaceutical JSC engaged in Pharmaceutical manufacturing and sale, sale of functional food.  Full Article

TAISHO PHARMACEUTICAL HOLDINGS raises consolidated mid-year outlook for FY 2016
Tuesday, 20 Oct 2015 02:00am EDT 

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd:Says the company increased the consolidated mid-year outlook for revenue to 146,000 mln yen from 144,000 mln yen, for the fiscal year ending March 2016.Operating profit forecast increased to 13,900 mln yen from 10,000 mln yen.Ordinary profit forecast increased to 17,700 mln yen from 14,000 mln yen.Net profit forecast increased to 11,300 mln yen from 8,500 mln yen.Earnings per share increased to 139.39 yen from 104.86 yen.Comments improvements in core business and cost reduction are the main reasons for the forecast.  Full Article

TAISHO PHARMACEUTICAL HOLDINGS receives announces approval of percutaneous absorption-type analgesic anti-inflammatory agent in Japan
Monday, 28 Sep 2015 01:30am EDT 

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd:Obtained the marketing approval of its percutaneous absorption-type analgesic anti-inflammatory agent for treatment of analgesic, anti-inflammatory in osteoarthritis in Japan.  Full Article